Company intelligence / Profile preview

Regulatory Insight

Ownership: Private
Development stage: Other

Overview

Regulatory Insight is an active, independent consulting firm specializing in global regulatory compliance and submissions for medical device and in vitro diagnostic manufacturers. The company assists clients with FDA approvals, CE Marking, Health Canada licensing, Australian TGA approval, quality system design compliant with FDA’s Quality System Regulation and ISO 13485 standards, UDI/GUDID requirements, reportable events/recalls management, and comprehensive training services. It is not a therapeutic or product development company.

Industry: Consulting

Beyond the preview

Go deeper on Regulatory Insight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regulatory Insight.

Explore the full profile